Fundamental Analysis · Last Quarter

FA

A dedicated fundamental analysis might help you to get a quick overview of the financial stability. However it is important to understand the FA Algorithm and the criterias before valuing it as a solution.

See FA Rationale
Framework:
Valuation Somewhat Positive
56%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA -97.91 10.50 502.42
Graham Fair Price 17.65 32.50 27.63
PEG -31.89 0.24 -0.35
Price/Book -2.00 0.90 0.91
Price/Cash Flow 133.40 2.99 -1.28
Prices/Earnings -19.30 4.45 5.51
Price/Sales 130.47 4.59 1.99
Price/FCF 133.40 2.99 -1.28
Naive Interpretation member
01 - Valuation · Somewhat Positive
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin 0.00 1.00 1.00
Operating Margin 2864.48 0.27 < 0.005
ROA 21.18 < 0.005 < 0.005
ROE 0.04 0.05 21.44
ROIC < 0.005 < 0.005 1456.77
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ -0.86 1.92 -55.26
Dividends QOQ 0.00 -1.00 -100.00
EBIT QOQ -0.94 12.46 1231.10
EPS QOQ -0.16 0.18 18.49
FCF QOQ -7.96 1.45 -81.80
Revenue QOQ 1.27 -0.55 -56.98
Naive Interpretation member
03 - Financial Growth · Balanced
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 0.00 0.00 0.00
Days Sales Outstanding (DSO) 62.53 137.30 119.56
Inventory Turnover 0.00 0.00 0.00
Debt/Capitalization 0.86 0.85 -1.25
Quick Ratio -0.06 5.08 7883.66
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 28.59 30.52 6.76
Cash -20.88 33.50 60.47
Capex -0.27 -0.13 52.80
Free Cash Flow -20.38 9.14 -55.17
Revenue 13.12 5.95 -54.60
Naive Interpretation member
05 - Per Share Metrics · Weak
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 0.14 5.08 3572.10
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 426.94 -5.05 -98.82
Naive Interpretation Member
06 - Financial Health · Bad
Rating